SaarIGillMD

PubMed

• Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.
  Matthew P Connor, Neeharika Prathapa, Noelle V Frey, Saar I Gill, Elizabeth O Hexner, Ximena Jordan Bruno, Catherine E Lai, Alison W Loren, Selina M Luger, Andrew H Ma...> ;Haematologica. 2024 Apr 18
• Characterization of the calcineurin inhibitor pain syndrome in patients undergoing allogeneic hematopoietic cell transplantation.
  Freyer, C., Carulli, A., Frey, N., Martin, M., Porter, D., Loren, A., Gill, S., Hexner, E., Luger, S., Stadtmauer, E.> ;Leukemia & Lymphoma. 2024 Feb 1
• Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients.
  Anthony D Sung, Thuy Koll, Shannon H Gier, Alessandro Racioppi, Griffin White, Meagan Lew, Marcia Free, Priyal Agarwal, Lauren M Bohannon, Ernaya J Johnson, Bharathi S...> ;Transplantation and Cellular Therapy. 2024 Apr 1
• Hypoimmune cells resist rejection in monkeys.
  Asuncion Borrero Borrego, Saar Gill> ;Nature Biotechnology. 2024 Mar 1
• 12 citations
  Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy.
  Nils Wellhausen, Ryan P O'Connell, Stefanie Lesch, Nils W Engel, Austin K Rennels, Donna Gonzales, Friederike Herbst, Regina M Young, K Christopher Garcia, David Weine...> ;Science Translational Medicine. 2023 Sep 20
• One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant.
  Lindsey Chippendale, Craig W Freyer, Alison Carulli, Daria V Babushok, Noelle V Frey, Saar I Gill, Elizabeth O Hexner, Selina M Luger, Mary Ellen Martin, David L Porte...> ;Journal of Oncology Pharmacy Practice. 2023 Aug 21
• 4 citations
  Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia.
  Katherine Cummins, Saar Gill> ;Hematology/oncology Clinics of North America. 2023 Dec 1
• 3 citations
  Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia.
  Andrew H Matthews, Alexander E Perl, Selina M Luger, Saar I Gill, Catherine Lai, David L Porter, Sarah Skuli, Ximena Jordan Bruno, Martin P Carroll, Craig W Freyer, Al...> ;American Journal of Hematology. 2023 Aug 1
• 2 citations
  Good CARMA: Turning bad tumor-resident myeloid cells good with chimeric antigen receptor macrophages.
  Christopher M Snyder, Saar I Gill> ;Immunological Reviews. 2023 Nov 1
• 2 citations
  A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement.
  Rohtesh S Mehta, Haris Ali, Yang Dai, Bert Yao, Bethany Overman, Voravit Ratanatharathorn, Saar Gill, Gerard Socié, Kevin Anderson, Jean Yves Cahn, Arshad Mujeebuddin,...> ;Bone Marrow Transplantation. 2023 Sep 1
• 5 citations
  CD38 as a pan-hematologic target for chimeric antigen receptor T cells.
  Tina Glisovic-Aplenc, Caroline Diorio, John A Chukinas, Kimberly Veliz, Olga Shestova, Feng Shen, Selene Nunez-Cruz, Tiffaney L Vincent, Fei Miao, Michael C Milone, Ca...> ;Blood Advances. 2023 Aug 22
• 18 citations
  Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies.
  Saygin, C., Roloff, G., Hahn, C., Chhetri, R., Gill, S., Elmariah, H., Talati, C., Nunley, E., Gao, G., Kim, A., Bishop, M., Kosuri, S., Das, S., Singhal, D., Venugopa...> ;Blood Advances. 2023 Feb 28
• 2 citations
  Author Correction: Decade-long leukaemia remissions with persistence of CD4CAR T cells.
  J Joseph Melenhorst, Gregory M Chen, Meng Wang, David L Porter, Changya Chen, McKensie A Collins, Peng Gao, Shovik Bandyopadhyay, Hongxing Sun, Ziran Zhao, Stefan Lund...> ;Nature. 2022 Dec 1
• 3 citations
  Cancer Immunotherapy Beyond Checkpoint Blockade:State-of-the-Art Review.
  Nathan E Welty, Saar I Gill> ;JACC. Cardiooncology. 2022 Dec 1
• 1 citations
  Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies.
  Matthew P Connor, Alison W Loren, Elizabeth O Hexner, Mary Ellen Martin, Saar I Gill, Selina M Luger, James K Mangan, Alexander E Perl, Shannon R McCurdy, Keith W Prat...> ;Transplantation and Cellular Therapy. 2023 Feb 1
• 2 citations
  Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy.
  Melody Smith, Anqi Dai, Guido Ghilardi, Kimberly V Amelsberg, Sean M Devlin, Raymone Pajarillo, John B Slingerland, Silvia Beghi, Pamela S Herrera, Paul Giardina, Anne...> ;Nature Medicine. 2023 Nov 1
• 13 citations
  Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer.
  Lee, Y., Guruprasad, P., Ghilardi, G., Pajarillo, R., Sauter, C., Patel, R., Ballard, H., Hong, S., Chun, I., Yang, N., Amelsberg, K., Cummins, K., Svoboda, J., Gill, ...> ;Cancer Discovery. 2022 Oct 5
• 1 citations
  Nomenclature for Cellular and Genetic Therapies: A Need for Standardization.
  Akshay Sharma, Stephanie Farnia, Folashade Otegbeye, Amy Rinkle, Jugna Shah, Nirali N Shah, Saar Gill, Marcela V Maus> ;Transplantation and Cellular Therapy. 2022 Dec 1
• 11 citations
  Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19.
  Caroline Diorio, Rawan Shraim, Regina Myers, Edward M Behrens, Scott Canna, Hamid Bassiri, Richard Aplenc, Chakkapong Burudpakdee, Fang Chen, Amanda M DiNofia, Saar Gi...> ;Clinical Cancer Research. 2022 Sep 1
• 33 citations
  Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia.
  Andrew H Matthews, Alexander E Perl, Selina M Luger, Alison W Loren, Saar I Gill, David L Porter, Daria V Babushok, Ivan P Maillard, Martin P Carroll, Noelle V Frey, E...> ;Blood Advances. 2022 Jul 12
• 1 citations
  Salvage therapy with basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease.
  Craig W Freyer, Shannon Gier, Alison Carulli, Saar I Gill, Elizabeth O Hexner, Alison W Loren, Mary Ellen Martin, David L Porter> ;American Journal of Hematology. 2022 Jul 1
• 4 citations
  Low-Dose Total Body Irradiation Added to Fludarabine and Busulfan Reduced-Intensity Conditioning Reduces Graft Failure in Patients with Myelofibrosis.
  Craig W Freyer, Daria V Babushok, Noelle V Frey, Saar I Gill, Alison W Loren, Selina M Luger, Amit Maity, Mary Ellen Martin, John P Plastaras, David L Porter, Elizabet...> ;Transplantation and Cellular Therapy. 2022 Sep 1
• 17 citations
  Antigen glycosylation regulates efficacy of CAR T cells targeting CD19.
  Amanda Heard, Jack H Landmann, Ava R Hansen, Alkmini Papadopolou, Yu-Sung Hsu, Mehmet Emrah Selli, John M Warrington, John Lattin, Jufang Chang, Helen Ha, Martina Haug...> ;Nature Communications. 2022 Jun 11
• Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant.
  Rachel V Hatch, Craig W Freyer, Alison Carulli, Gretchen Redline, Daria V Babushok, Noelle V Frey, Saar I Gill, Elizabeth O Hexner, Selina M Luger, Mary Ellen Martin, ...> ;Journal of Oncology Pharmacy Practice. 2022 Jun 1
• Epigenetic engineering empowers T cells.
  Jayesh V Tandel, Saar I Gill> ;Blood. 2022 Apr 7
• Join now to see all

Journal Articles

• Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-Exposure SARS-CoV-2 Prophylaxis Among Health Care Workers  
  Matthew C Hyman, Ian Frank, Scott E Hensley, Saar Gill, Dan T Vogl, Ivan Maillard, Daria V Babushok, Alexander C Huang, Sunita D Nasta, Jennifer C Walsh, Michael C Mil..., JAMA Internal Medicine
• Induction of Resistance to Chimeric Antigen Receptor T Cell Therapy by Transduction of a Single Leukemic B Cell  
  Vijay G Bhoj, David M Barrett, Carl H June, Stephan A Grupp, David E Ambrose, Saar I Gill, Marco Ruella, Bruce L Levine, Shannon L Maude, Nature
• Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium Difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients  
  Edward A Stadtmauer, James K Mangan, Elizabeth O Hexner, David L Porter, Daria V Babushok, Jacqueline Smith, Craig W Freyer, Mindy Schuster, Noelle V Frey, Selina M Lu..., Clinical Infectious Diseases
• Novel Approaches to Acute Myeloid Leukemia Immunotherapy  
  Saar Gill, MD, Clinical Cancer Research
• Non-Viral RNA Chimeric Antigen Receptor Modified T Cells in Patients with Hodgkin Lymphoma  
  Stephan A Grupp, Sunita Dwivedy Nasta, Susan R Rheingold, Daniel J Landsburg, Carl H June, Jakub Svoboda, Stephen J Schuster, Saar I Gill, David L Porter, Bruce L Levine, Blood
• Join now to see all

Abstracts/Posters

• Combined Venetoclax and Hypomethylating Agent (HMA) Therapy Induces High Response Rates in Patients with Myelodysplastic Syndrome Including Patients Previously Failing...
  Saar I. Gill, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Identification and Validation of Predictive Biomarkers to CD19- and BCMA-Specific CAR T-Cell Responses in CAR T-Cell Precursors
  Saar Gill, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Single Chain Variable Fragment Linker Length Regulates CAR Biology and T Cell Efficacy
  Saar I. Gill, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Fried Frailty Phenotype Predicts Mortality for Newly Diagnosed Older Patients with Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
  Saar I. Gill, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Career-Development Lunch Sessions: Adult Clinical Malignant Hematology/BMT 
  60th American Society of Hematology Annual Meeting - 12/1/2018
• Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Outcomes of Allogeneic Stem Cell Transplantation for AML and MDS Based on Pre-Transplant MRD Status By Next-Generation Sequencing 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Clinical Outcomes of Venetoclax Therapy in Patients with Relapsed/Refractory (r/r) Non Hodgkin Lymphomas (NHL) 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all